Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
Long-time pharma rivals unite to fight a common enemy: COVID-19

Long-time pharma rivals unite to fight a common enemy: COVID-19

Wall Street Journal | 
In the age of Covid-19, old adversaries are uniting around a common enemy: the new coronavirus. Their nascent partnership is ...
coronavirus drugs

Infographic: From vaccines to drugs, chasing ‘silver bullets’ targeting the fast-moving coronavirus

Wall Street Journal | 
For drug companies, there is suddenly only one priority: the coronavirus. More than 140 experimental drug treatments and vaccines for ...

Can Myriad Genetics maintain hold on breast cancer tests two years after loss of patents?

Wall Street Journal | 
Myriad Genetics Inc., used a patent-protected monopoly to become one of the most successful and controversial DNA testing companies in the world ...
cancer ribbon

Myriad BRCA test Medicare reimbursement rate (and price?) cut

Wall Street Journal | 
Medicare reimbursement rates for a popular genetic breast cancer test will drop by half in the new year as a ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists